![Thomas Strack](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas Strack
Technik-/Wissenschafts-/F&E-Leiter bei VTV THERAPEUTICS INC.
Aktive Positionen von Thomas Strack
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VTV THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 02.11.2023 | - |
Karriereverlauf von Thomas Strack
Ehemalige bekannte Positionen von Thomas Strack
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Faeth Therapeutics, Inc.
![]() Faeth Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Faeth Therapeutics, Inc. is a clinical-stage biotechnology company based in TX. The American company focuses on developing precision therapies for metabolic oncology using a machine-learning platform and a metabolic regimen involving the patient's diet. Faeth's lead program combines FTH-001 and FTH-003 with an insulin suppressing regimen to slow tumor growth by shutting down the PI3K/MTOR pathway. The company's scientific founders include Drs. Lew Cantley, Sid Mukherjee, and Karen Vousden. Anand Parikh has been the CEO since incorporation. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Takeda Global Research & Development Center, Inc. | Corporate Officer/Principal | - | - |
Asubio Pharmaceutical, Inc.
![]() Asubio Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Asubio Pharmaceutical, Inc. was into pharmaceuticals sector. The company was headquartered in Paramus, NY. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
PROGENICS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.09.2015 | - |
Ausbildung von Thomas Strack
The Johannes Gutenberg University of Mainz | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Deutschland | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
VTV THERAPEUTICS INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Progenics Pharmaceuticals, Inc.
![]() Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
Takeda Global Research & Development Center, Inc. | |
Asubio Pharmaceutical, Inc.
![]() Asubio Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Asubio Pharmaceutical, Inc. was into pharmaceuticals sector. The company was headquartered in Paramus, NY. | Health Technology |
Faeth Therapeutics, Inc.
![]() Faeth Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Faeth Therapeutics, Inc. is a clinical-stage biotechnology company based in TX. The American company focuses on developing precision therapies for metabolic oncology using a machine-learning platform and a metabolic regimen involving the patient's diet. Faeth's lead program combines FTH-001 and FTH-003 with an insulin suppressing regimen to slow tumor growth by shutting down the PI3K/MTOR pathway. The company's scientific founders include Drs. Lew Cantley, Sid Mukherjee, and Karen Vousden. Anand Parikh has been the CEO since incorporation. | Health Technology |
- Börse
- Insiders
- Thomas Strack
- Erfahrung